Navigation Links
With Hormone Therapy, Starting Later May Be Less Risky
Date:1/31/2011

MONDAY, Jan. 31 (HealthDay News) -- Women who begin hormone therapy at menopause, or before, face a greater risk for breast cancer than those who start the treatment later, a new study has found.

Though a number of earlier studies had concluded that hormone therapy increases breast cancer risk, the researchers wanted to know whether the timing of the therapy influences that risk, something they said few studies had examined.

To do that, they analyzed data from 1.13 million participants in the Million Women Study in the United Kingdom, concluding that the length of time between menopause and starting hormone therapy has a "substantial" effect on breast cancer risk.

Compared with women who began hormone therapy before or soon after menopause, those who started hormone therapy five years or more after menopause had little or no increased risk, the study found. The difference in risk was evident regardless of the type of hormone therapy, how long women used it and whether women were normal weight, overweight or obese.

The findings, published online Jan. 28 in the Journal of the National Cancer Institute, support similar findings from the Women's Health Initiative study in the United States, two experts wrote in an accompanying editorial.

More information

The American Cancer Society has more about hormone therapy and breast cancer risk.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, Jan. 28, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Pioneering Hormone Therapist to Host Free Health Seminar
2. Hormone May Prevent Aggressive Breast Cancer
3. Bonding Hormone Might Help Some With Autism
4. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
5. Early On, Hormone Therapy May Raise Womens Heart Risks
6. Testicular Cancer Survivors May Have Hormone Deficiency
7. Stress hormone, depression trigger obesity in girls
8. Buy HGH Website Educates Consumers on the Pros and Cons of Human Growth Hormone Supplements
9. Hormone thought to slow aging associated with increased risk of cancer death
10. Hormone Outperforms Insulin in Diabetic Mice
11. High Hormone Level Linked to Cancer Death in Older Men
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
With Hormone Therapy, Starting Later May Be Less Risky
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Regenerative ... Best Places to Work employee satisfaction survey, earning them second place for Tampa’s Best ... with 25-49 employees. , “This is a great accomplishment for our team,” says ...
(Date:4/29/2016)... Village, CA (PRWEB) , ... April 29, 2016 ... ... Philadelphia Pet Expo to promote their animal line of probiotics, Petbiotics ™, ... see the large turnout of animal rescue groups networking for their non-profit organizations. ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... detailing the company’s use of Microsoft Dynamics GP for one their long-term care ... solution that integrated Dynamics GP with key clinical management systems, and delivered a ...
(Date:4/29/2016)... ... 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... AD, saying it is time to set the record straight. Traditionally, BC and AD ... cannot possibly be true and offers explanation. , “To start with, the Name of ...
(Date:4/28/2016)... , ... April 29, 2016 , ... Monthly subscription boxes ... on the market. They recently reviewed the ZEN BOX , the aromatherapy subscription ... two single essential oils (like lavender or frankincense) and one Zen Blend (like immune ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , April 27, 2016 ... initiative to save newborns   ... for women & newborns in collaboration with Breast Milk Foundation ... the first Pasteurized Human Milk Bank, ,Amaara, in Delhi-NCR today. ... nutritional food source for infants and should be available to ...
(Date:4/27/2016)... NEW YORK , April 27, 2016 /PRNewswire/ ... OASM ), a developer of a new ... today announced positive overall survival results for Paclical/Apealea ... total of 789 patients with epithelial ovarian cancer. ... treatment groups: Paclical/Apealea in combination with carboplatin versus ...
(Date:4/26/2016)... Mich. , April 26, 2016 Diplomat ... promotion of Jennifer Hagerman , Pharm D., to ... her growing role at Diplomat, Hagerman will continue to ... the company that delivers custom education and training to ... the specialty pharmacy industry. Diplomat University also houses the ...
Breaking Medicine Technology: